Institutional investors purchased a net $976.3 thousand shares of ZIOP during the quarter ended December 2017 and now own 33.48% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KLP KAPITALFORVALTNING AS Bought 15.1 Thousand shares of ZIOPHARM Oncology Inc
RAYMOND JAMES FINANCIAL SERVICES... Bought 3.5 Thousand shares of ZIOPHARM Oncology Inc